Heparin-Binding Protein and Heparins
- Conditions
- ThromboprophylaxisVascular Disease, PeripheralCardiovascular Diseases
- Interventions
- Diagnostic Test: Blood samples for Heparin-binding protein measurement
- Registration Number
- NCT04146493
- Lead Sponsor
- Halla Halldorsdottir
- Brief Summary
Heparin-Binding protein is a protein from primary and secretory granluae of white blood cells. It is released when white blood cells become activated and has been advocated as a biomarker for sepsis. The aim of this study is to find out if Heparins in clinical doses can change the level of Heparin-binding protein in plasma.
- Detailed Description
Blood samples are taken from patients before and after Heparins in clinical doses. The effects of heparins on Heparin-binding protein concentration in plasma is measured. This is a small observational study.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 60
- Planned endovascular treatment of aortic aneurysm or peripheral vascular surgery where unfractionated heparin in >3000 units are given perioperatively
- Planned subcutaneous low molecular weight heparin as a thromboprophylactic treatment after major surgery or on Intensive Care treated patients.
- Planned open heart surgery with cardiopulmonary bypass.
- Under 18 years
- Unable to get informed consent from patient or relative
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Thromboprophylaxis group Blood samples for Heparin-binding protein measurement Patients which are given low molecular heparins as a thrombosprofylax after major surgery Vascular surgery group Blood samples for Heparin-binding protein measurement Patients which are given unfractionated heparin during their vascular surgery. Cardiothoracic surgery Blood samples for Heparin-binding protein measurement Patients which are given high dose unfractionated heparin during their open heart surgey
- Primary Outcome Measures
Name Time Method Changes in the level of Heparin-binding protein Repeated blood sampling during minimum of 1 hour and maximum of 5 hours after given heparin Blood samples are taken before and after given heparin
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Halla Halldorsdottir
πΈπͺStockholm, Solna, Sweden